Benitec Biopharma Inc (BNTC) returns
Benitec Biopharma returns over 10 years
$1,000 invested in Benitec Biopharma ten years ago was worth $21.72 at the close on October 30, 2026, with dividends reinvested: an average return of -31.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -12.6% | — | $874.00 | -0.9% |
| 3 months | -26.3% | — | $736.93 | +2.1% |
| Year to date | -35.1% | — | $648.85 | +11.7% |
| 1 year | -45.9% | — | $540.51 | +12.4% |
| 3 years | +146.2% | +35.0% | $2,462 | +88.5% |
| 5 years | -86.0% | -32.5% | $140.47 | +76.0% |
| 10 years | -97.8% | -31.8% | $21.72 | +316.6% |
Benitec Biopharma return by calendar year
| Year | BNTC | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -35.1% | +11.7% | -46.8% |
| 2025 | +6.7% | +17.7% | -11.1% |
| 2024 | +291.0% | +24.9% | +266.1% |
| 2023 | +11.8% | +26.2% | -14.4% |
| 2022 | -93.5% | -18.2% | -75.3% |
| 2021 | -12.7% | +28.7% | -41.4% |
| 2020 | -60.8% | +18.4% | -79.2% |
| 2019 | -66.0% | +31.2% | -97.2% |
| 2018 | -49.3% | -4.6% | -44.7% |
| 2017 | +93.5% | +21.7% | +71.8% |
| 2016 | -61.9% | +12.0% | -73.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: BNTC financials
No forecast, no recommendation. This page describes Benitec Biopharma Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.